Xinhua News Agency, June 10, the State Drug Administration recently approved the application for registration of innovative products of multimodal tumor treatment system produced by Shanghai Meijie Medical Technology Co., Ltd. The product is a multimodal therapy system that integrates liquid nitrogen freezing and radio frequency heating. By pre-freezing the target focus, followed by radio frequency heating and precise control of the process, the multimodal tumor ablation of the coincidence of the heating area and the frozen area can be realized, and the accurate treatment effect of the focus can be achieved.